Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCost Effectiveness of Imatinib, Dasatinib, and Nilotinib as First-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia in China.AuthorsLi, Na; Zheng, Bin; Cai, Hong-Fu; Yang, Jing; Luo, Xiao-Feng; Weng, Li-Zhu; Zhan, Feng-Mei; Liu, Mao-BaiPublicationClinical Drug Investigation, 2018, Vol 38, Issue 1, p79ISSN1173-2563Publication typeArticleDOI10.1007/s40261-017-0587-z